Octave Specialty Group Inc.

Last updated September 27, 2026

Organization details

Legal name
Octave Specialty Group Inc.
Former names
Ambac Financial Group Inc Ambac Inc
Ownership
Public
Status
Active
Sector (GICS)
Financials
SIC code
6351 — Surety Insurance
Jurisdiction of incorporation
Delaware
Headquarters city
New York
Headquarters state / province
New York
Headquarters country
United States
Fiscal year end
December
Ticker symbol
OSG
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000874501
EIN
13-3621676

Board of directors

Chief executives

Claude LeBlanc · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of May 28, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 7 other boards. 4 are in the same sector.

Network of Octave Specialty Group Inc.'s board connections Equitable Holdings Inc. Equitable Holdings Inc... Aegon Ltd. New York Registry Aegon Ltd. New York Re... Cerence Inc. Cerence Inc. DXC Technology Company DXC Technology Company Fermi Inc. Fermi Inc. MetLife Inc. MetLife Inc. Unum Group Unum Group David L. Herzog David L. Herzog Jeffrey Scott Stein Jeffrey Scott Stein Joan M. Lammtennant Joan M. Lammtennant Kristi Ann Matus Kristi Ann Matus Octave Specialty Group Inc...
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$91,080
1 purchase by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 3, 2026 Claude LeBlanc Director, Officer (Chief Executive Officer) Option exercise +15,229 — —
Oct 3, 2026 Trick David Officer (Exec VP, CFO & Treasurer) Option exercise +3,047 — —
Oct 3, 2026 Smith R Sharon Officer (Exec VP & Group COO) Option exercise +2,539 — —
Oct 3, 2026 Claude LeBlanc Director, Officer (Chief Executive Officer) Shares withheld for tax −8,421 $4.60 $38,737
Oct 3, 2026 Trick David Officer (Exec VP, CFO & Treasurer) Shares withheld for tax −3,047 $4.60 $14,016
Oct 3, 2026 Smith R Sharon Officer (Exec VP & Group COO) Shares withheld for tax −2,539 $4.60 $11,679
Oct 3, 2026 Claude LeBlanc Director, Officer (Chief Executive Officer) Option exercise +11,628 — —
Oct 3, 2026 Claude LeBlanc Director, Officer (Chief Executive Officer) Shares withheld for tax −11,638 $4.60 $53,535
Jul 9, 2026 Claude LeBlanc Director, Officer (Chief Executive Officer) Option exercise +39,380 — —
Jul 9, 2026 Trick David Officer (Exec VP, CFO & Treasurer) Option exercise +13,206 — —
Jul 9, 2026 Smith R Sharon Officer (Exec VP & Group COO) Option exercise +11,779 — —
Jul 9, 2026 Claude LeBlanc Director, Officer (Chief Executive Officer) Shares withheld for tax −21,777 $6.08 $132,404
Jul 9, 2026 Trick David Officer (Exec VP, CFO & Treasurer) Shares withheld for tax −6,741 $6.08 $40,985
Jul 9, 2026 Smith R Sharon Officer (Exec VP & Group COO) Shares withheld for tax −4,635 $6.08 $28,181
Mar 10, 2026 Ahn Cristina E. Officer (Chief Accounting Officer) Option exercise +835 — —

Organizations in the same sector, closest in location and size first.

Questions about Octave Specialty Group Inc.

Who is the CEO of Octave Specialty Group Inc.?

Claude LeBlanc is Octave Specialty Group Inc.'s Chief Executive Officer.

How many directors are on Octave Specialty Group Inc.'s board?

Octave Specialty Group Inc.'s board has 9 directors: C. James Prieur, Claude LeBlanc, David L. Herzog, Ian David Haft, Jeffrey Scott Stein, Joan M. Lammtennant, Kristi Ann Matus, Lisa G. Iglesias and Michael D. Price.

Are Octave Specialty Group Inc. insiders buying or selling shares?

Over the last 12 months, Octave Specialty Group Inc. insiders bought $91,080 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="octave-specialty-group-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.